Wenlong Huang

4.9k total citations
222 papers, 4.1k citations indexed

About

Wenlong Huang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Wenlong Huang has authored 222 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 58 papers in Organic Chemistry and 45 papers in Oncology. Recurrent topics in Wenlong Huang's work include Cancer therapeutics and mechanisms (38 papers), Drug Transport and Resistance Mechanisms (31 papers) and Diabetes Treatment and Management (31 papers). Wenlong Huang is often cited by papers focused on Cancer therapeutics and mechanisms (38 papers), Drug Transport and Resistance Mechanisms (31 papers) and Diabetes Treatment and Management (31 papers). Wenlong Huang collaborates with scholars based in China, Australia and United States. Wenlong Huang's co-authors include Hai Qian, Qianqian Qiu, Zheng Li, Wei Shi, Sharon Evans, John P. Newnham, Chunlei Tang, Shu Chen, Yuxuan Dai and Huibin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Wenlong Huang

214 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenlong Huang China 33 1.8k 755 637 589 507 222 4.1k
Akira Yamamoto Japan 44 2.4k 1.4× 318 0.4× 1.3k 2.1× 236 0.4× 359 0.7× 220 7.2k
Tom C. Karagiannis Australia 38 3.6k 2.0× 339 0.4× 849 1.3× 205 0.3× 138 0.3× 141 5.8k
Robert T. Dorr United States 43 2.4k 1.4× 996 1.3× 1.5k 2.3× 164 0.3× 238 0.5× 157 6.1k
Huy Ong Canada 37 2.0k 1.1× 339 0.4× 401 0.6× 528 0.9× 105 0.2× 140 4.4k
William G. Helferich United States 43 2.1k 1.2× 311 0.4× 1.1k 1.8× 694 1.2× 194 0.4× 117 6.7k
Ichiro Mori Japan 44 2.2k 1.3× 554 0.7× 1.2k 1.9× 651 1.1× 161 0.3× 203 5.6k
Alessandra di Masi Italy 31 2.6k 1.5× 174 0.2× 748 1.2× 164 0.3× 345 0.7× 118 4.7k
Shozo Muranishi Japan 37 1.6k 0.9× 344 0.5× 869 1.4× 224 0.4× 361 0.7× 232 5.0k
Eu‐Leong Yong Singapore 42 3.5k 2.0× 145 0.2× 502 0.8× 1.3k 2.3× 276 0.5× 174 7.0k
Riccardo Ghidoni Italy 48 5.4k 3.0× 955 1.3× 367 0.6× 387 0.7× 163 0.3× 159 7.6k

Countries citing papers authored by Wenlong Huang

Since Specialization
Citations

This map shows the geographic impact of Wenlong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlong Huang more than expected).

Fields of papers citing papers by Wenlong Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlong Huang. The network helps show where Wenlong Huang may publish in the future.

Co-authorship network of co-authors of Wenlong Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlong Huang. A scholar is included among the top collaborators of Wenlong Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlong Huang. Wenlong Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xi, Qiaoyu Li, Tingting Liu, et al.. (2025). Giardia duodenalis triggered neutrophil extracellular traps in goats. Immunobiology. 230(3). 152894–152894. 1 indexed citations
2.
Xie, Jun, et al.. (2025). Supramolecular Nanoplatform for Biofilm Eradication and Anti‐inflammatory by Phototherapies and Macrophage Repolarization. Advanced Healthcare Materials. 14(23). e2501162–e2501162.
3.
Huang, Wenlong, et al.. (2025). A Bacteria-Targeting Supramolecular Nanophotosensitizer for Combating Multidrug Resistant Bacteria. ACS Biomaterials Science & Engineering. 11(3). 1741–1750. 2 indexed citations
4.
Gao, Rui, Danfeng Zhang, X.Q. Wang, et al.. (2025). Lanthanide-doped fluoride glass-ceramics for high temperature X-ray imaging. Ceramics International. 51(25). 46926–46932.
5.
Yang, Shuyi, Wenlong Huang, Mu‐Hung Tsai, et al.. (2024). Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis. Molecular Carcinogenesis. 64(3). 440–449. 3 indexed citations
6.
Wang, Guohao, Ting Wang, Lihui Hou, et al.. (2024). Regulation of Intrinsic Defects of Self‐Activated MgGa2O4 Phosphors for Temperature Dynamic Anti‐Counterfeiting. Laser & Photonics Review. 18(12). 11 indexed citations
7.
Zhou, Jiaqi, et al.. (2021). A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability. Bioorganic Chemistry. 117. 105453–105453. 23 indexed citations
9.
Li, Yuanyuan, et al.. (2019). Synthesis and Antitumor Activities of C-3 Thiazolotriazole Unsaturated Ketone Derivatives of Levofloxacoin. Chinese Journal of Applied Chemistry. 36(6). 671–676. 1 indexed citations
10.
Pan, Miaobo, Jian Cui, Chen Liao, et al.. (2017). Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors. Bioorganic & Medicinal Chemistry. 25(15). 4194–4202. 10 indexed citations
11.
Huang, Wenlong, et al.. (2016). CaZr_1Sc‐O_3セラミックの作製とイオン伝導【Powered by NICT】. Ceramics International. 42(12). 13410. 1 indexed citations
12.
Yan, Qiang, et al.. (2015). Synthesis and antitumor activity of C-3 thiazolo 3 2-b 1 2 4 triazole-substituted pefloxacin derivatives. Zhongguo yaoke daxue xuebao. 548–551. 2 indexed citations
13.
Hu, Guoqiang, et al.. (2012). Design, Synthesis and Antitumor Activity of Fluoroquinolone C3 Heterocyclic Bis-oxadiazole Methylsulfide Derivatives Derived from Levofloxacin. Chemical Research in Chinese Universities. 28(6). 980–984. 5 indexed citations
14.
Lu, Dong & Wenlong Huang. (2010). Overview of drug evaluation system in China. Scientific Research and Essays. 5(6). 514–518. 2 indexed citations
15.
Huang, Wenlong. (2010). Synthesis and Antibacterial Activity of Fluoroquinolone C-3 Acylhydrazones. Zhōnghuá yàoxué zázhì. 1 indexed citations
16.
Huang, Wenlong. (2010). Effect of sarpogrelate (Anplag) versus cilostazol on the peripheral artery disease in patients with type 2 diabetes:A randomized and controlled trial. 3 indexed citations
17.
Huang, Wenlong. (2009). Discussion about evaluation on post-marketing drug. The Chinese Journal of Clinical Pharmacology.
18.
Huang, Wenlong. (2008). Evolution of Quality Control Models for Drug Products in China. Chinese Journal of Pharmaceuticals. 1 indexed citations
19.
Hu, Guoqiang, Sheng Li, & Wenlong Huang. (2006). Synthesis of Pyridyl Polyheterocyclic Oxime-ether Schiff Bases Containing s-Triazole and Oxadiazole Subunits. Chinese Chemical Letters. 17(7). 899–902. 1 indexed citations
20.
Huang, Wenlong, C Harper, Sharon Evans, John P. Newnham, & Sarah A. Dunlop. (2001). Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. International Journal of Developmental Neuroscience. 19(4). 415–425. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026